Wikell, C <br/><br/>
Effect of halving the dose of venlafaxine to adjust for putative pharmacokinetic and pharmacodynamic changes in an animal model of chronic hepatic encephalopathy.  [electronic resource] 

 -  Clinical neuropharmacology   
 - 324-33 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0362-5664 
<br/><br/><label>Standard No.: </label>10.1097/00002826-200111000-00003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Biotransformation<br/>Brain Chemistry--drug effects<br/>Chronic Disease<br/>Cyclohexanols--administration & dosage<br/>Disease Models, Animal<br/>Dopamine--metabolism<br/>Dose-Response Relationship, Drug<br/>Half-Life<br/>Hepatic Encephalopathy--drug therapy<br/>Male<br/>Microdialysis<br/>Norepinephrine--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Serotonin--metabolism<br/>Selective Serotonin Reuptake Inhibitors--administration & dosage<br/>Venlafaxine Hydrochloride